XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.

Oncogene

Volumn 16, Issue 17, 1998, Pages 2205-2212

  De Vries, Annemieke ^a,b,d   Berg, Rob J W ^a   Wijnhoven, Susan ^b   Westerman, Anja ^b   Wester, Piet W ^c   Van Kreijl, Coen F ^b   Capel, Peter J A ^a   De Gruijl, Frank R ^a   Van Kranen, Henk J ^b   Van Steeg, Harry ^b,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c Lab of Pathology and Immunobiology   (Netherlands)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

p53; Papilloma; ras; Squamous cell carcinoma; UVB; XPA

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOMA; GENE MUTATION; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL; ULTRAVIOLET B RADIATION; XERODERMA PIGMENTOSUM;

ANIMALIA;

EID: 7144251887     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201744     Document Type: Article

References (38)

1. Ananthaswamy HN and Pierceall WE. (1990). Photochem. Photobiol., 52, 1119-1136.
2. Berg RJW, De Gruijl FR and Van der Leun JC. (1993). Cancer Res., 53, 4212-4217.
3. Berg RJW, Van Kranen HJ, Rebel HG, De Vries A, Van Vloten WA, Van Kreijl CF, Van der Leun JC and De Gruijl FR. (1996). Proc. Natl. Acad. Sci. USA, 93, 274-278.
4. Berg RJW, De Vries A, Van Steeg H and De Gruijl FR. (1997). Cancer Res., 57, 581-584.
5. Brash DE, Rudolph JA, Simon JA, Lin A, MeKenna JG, Baden HP, Halperin AJ and Ponten J. (1991). Proc. Natl. Acad. Sci. USA, 88, 10124-10128.
6. Bredberg A, Kraemer KH and Seidman MM. (1986). Proc. Natl. Acad. Sci. USA, 83, 8273-8277.
7. Brown K, Buchmann A and Balmain A. (1990). Proc. Natl. Acad. Sci. USA, 87, 538-542.
8. Brown K, Burns PA and Balmain A. (1995). Toxicology Letters, 82/83, 123-130.
9. Campbell C, Quinn AG and Rees JL. (1993). Br. J. Dermatol., 128, 111-114.
10. Cleaver JE and Kraemer KH. (1995). The Metabolic and Molecular Basis of Inherited Disease Scriver CR, Beaudet AL, Sly WS, Valle D. (eds) Seventh Edition (Vol III), pp 4393-4419. McGraw-Hill, New York.
11. Daya-Grosjean L, Dumaz N and Sarasin A. (1995). J. Photochem. Photobiol., 28, 115-124.
12. De Gruijl FR, Sterenborg HJ, Forbes PD, Davies RE, Cole C, Kelfkens G, Van Weelden H, Slaper H and Van der Leun JC. (1993). Cancer Res., 53, 53-60.
13. De Gruijl FR and Forbes PD. (1995). BioEssays, 17, 651-660.
14. De Vries A, Van Oostrom CTM, Hofhuis FMA, Dortant PM, Berg RJW, De Gruijl FR, Wester PW, Van Kreijl CF, Capel PJA, Van Steeg H and Verbeek SJ. (1995) Nature, 377, 169-173.
15. Dorado G, Steingrimsdottir H, Arlett CF and Lehmann AR. (1991). J. Mol. Biol., 217, 217-222.
16. Dumaz N, Stary A, Soussi T, Daya-Grosjean L and Sarasin A. (1994). Mutation Res., 307, 375-386.
17. Dumaz N, Van Kranen HJ, De Vries A, Berg RJW, Wester PW, Van Kreijl CF, Sarasin A, Daya-Grosjean L and De Gruijl FR. (1997). Carcinogenesis, 18, 897-904.
18. IARC. Monographs on the evaluation of carcinogenic risk to humans, Vol. 55. International Agency for Research on Cancer, Lyon (1992).
19. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML and Ananthaswamy HN. (1993). Cancer Res., 53, 2961-2964.
20. Kraemer KH. (1997). Proc. Natl. Acad. Sci. USA, 94, 11-14.
21. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J and Schwarz M. (1992). Cancer Res., 52, 6400-6403.
22. Lehmann AR. (1995). Trends Biochem. Sci., 20, 402-405.
23. Lungmann M and Zhang F. (1996). Oncogene, 13, 823-831.
24. Matsumura Y, Sato M, Nishigori C, Zghal M, Yagi T, Imamura S and Takebe H. (1995). J. Invest. Dermatol., 105, 399-401.
25. Matsumura Y, Nishigori C, Yagi T, Imamura S and Takebe H. (1996). Int. J. Cancer, 65, 778-780.
26. Mitra G, Pauly GT, Kumar R, Pei GK, Hughes SH, Moschel RC and Barbacid M. (1989). Proc. Natl. Acad. Sci. USA, 86, 8650-8654.
27. Miyauchi-Hashimoto H, Tanaka K and Horio T. (1996). J. Invest. Derm., 107, 343-348.
28. Mukhtar H and Elmets CA. (1996). Photochem. Photobiol., 63, 356-357.
29. Nataraj AJ, Trent JC and Ananthaswamy HN. (1995). Photochem. Photobiol., 62, 218-230.
30. Rees J. (1994). J. Invest. Dermatol., 103, 747-750.
31. Ruven HJT, Seelen CM, Lohman PH, Van Kranen H, Van Zeeland AA and Mullenders LHF. (1994). Oncogene, 9, 3427-3434.
32. Sato M, Nishigori C, Zghal M, Yagi T and Takehe H. (1993). Cancer Res., 53, 2944-2946.
33. Van der Schroeff JG, Evers LM, Boot AJM and Bos JL. (1990). J. Invest. Dermatol., 94, 423-425.
34. Van Kranen HJ, De Gruijl FR, De Vries A, Sontag Y, Wester PW, Senden HC, Rozemuller E and Van Kreijl CF. (1995). Carcinogenesis, 16, 1141-1147.
35. Van Kranen HJ, De Laat A, Van de Ven J, Wester PW, De Vries A, Berg RJW, Van Kreijl CF and De Gruijl FR. (1997). Cancer Res., 57, 1238-1240.
36. Yagi T, Tatsumi J, Sato M, Kraemer KH and Takebe H. (1991). Cancer Res., 51, 3177-3182.
37. Ziegler A, Leffell DJ, Kanula S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE and Brash DE. (1993). Proc. Natl. Acad. Sci. USA, 90, 4216-4220.
38. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. (1994). Nature, 372, 773-776.